Choi Eunkyung, Kim Donggyeong, Jeon Younghoon
Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University Hospital Department of Anesthesiology and Pain Medicine, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea.
Medicine (Baltimore). 2016 Dec;95(51):e5153. doi: 10.1097/MD.0000000000005153.
Propofol, an intravenous anesthetic, often causes pain on injection, which can be very distressful to patients. We investigated the analgesic effect of pregabalin on pain following propofol injection, compared with lidocaine.
In a randomized, double-blind, prospective trial, 120 patients were randomized into 3 groups of 40 each; who received oral placebo and intravenous lidocaine 40 mg with venous occlusion for 1 minute (group L, n = 40), oral pregabalin 75 mg and intravenous normal saline with venous occlusion for 1 minute (group LP, n = 40), and oral pregabalin 150 mg and intravenous normal saline with venous occlusion for 1 minute (group HP, n = 40) as pretreatment, followed by administration of 1% propofol 0.5 mg/kg. Pain intensity was measured on a 4-point scale (0 = no, 1 = mild, 2 = moderate, and 3 = severe pain). Any side effects associated with pretreatment substances were recorded during the first 24 hours after surgery.
A total of 120 patients completed this trial. Demographic data were similar between groups. The incidence of pain following propofol injection was significantly reduced in group HP (50%) and group L (55%) compared with group LP (92.5%) (P < 0.05, respectively). The incidences of moderate pain in group HP (12.5%) and group L (15%) were significantly decreased compared with group LP (37.5%; both, P < 0.05). There were no significant differences in the incidence of side effects such as headache and dizziness between groups.
Pretreatment with oral pregabalin 150 mg and intravenous lidocaine 40 mg with venous occlusion equally reduced pain from propofol injection.
丙泊酚是一种静脉麻醉剂,注射时常引起疼痛,这会给患者带来极大痛苦。我们研究了普瑞巴林与利多卡因相比,对丙泊酚注射后疼痛的镇痛效果。
在一项随机、双盲、前瞻性试验中,120例患者被随机分为3组,每组40例;分别接受口服安慰剂和静脉注射40毫克利多卡因并静脉阻断1分钟(L组,n = 40)、口服75毫克普瑞巴林和静脉注射生理盐水并静脉阻断1分钟(LP组,n = 40)、口服150毫克普瑞巴林和静脉注射生理盐水并静脉阻断1分钟(HP组,n = 40)作为预处理,随后给予1%丙泊酚0.5毫克/千克。疼痛强度采用4分制进行测量(0 = 无,1 = 轻度,2 = 中度,3 = 重度疼痛)。在术后的头24小时内记录与预处理药物相关的任何副作用。
共有120例患者完成了该试验。各组间人口统计学数据相似。与LP组(92.5%)相比,HP组(50%)和L组(55%)丙泊酚注射后疼痛的发生率显著降低(P均<0.05)。与LP组(37.5%)相比,HP组(12.5%)和L组(15%)中度疼痛的发生率显著降低(两者P均<0.05)。各组间头痛、头晕等副作用的发生率无显著差异。
口服150毫克普瑞巴林联合静脉注射40毫克利多卡因并静脉阻断预处理,对丙泊酚注射所致疼痛的缓解效果相当。